Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial
- 1 May 2005
- journal article
- clinical trial
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 16 (3) , 267-275
- https://doi.org/10.1111/j.1399-3038.2005.00216.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Validation of the classification of ARIA (allergic rhinitis and its impact on asthma)Allergy, 2003
- Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 2003
- Safety of fexofenadine in children treated for seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2001
- Allergic rhinitis: Definition, epidemiology, pathophysiology, detection, and diagnosisJournal of Allergy and Clinical Immunology, 2001
- Quality of life in adults and children with allergic rhinitisJournal of Allergy and Clinical Immunology, 2001
- The Course of Asthma Parallels that of Allergic Rhinitis: A 23-Year Follow-Up Study of College StudentsAllergy and Asthma Proceedings, 2000
- Therapeutic approaches to allergic rhinitis: Treating the childJournal of Allergy and Clinical Immunology, 2000
- Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of RhinitisAnnals of Allergy, Asthma & Immunology, 1998
- Measuring quality of life in children with rhinoconjunctivitisJournal of Allergy and Clinical Immunology, 1998
- Is allergic rhinitis more frequent in young adults with extreme shyness? A preliminary survey.Psychosomatic Medicine, 1990